Auction

Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited

Retrieved on: 
Thursday, December 14, 2023
UK Commercial Property Trust, Commercial property, Disclosure, The Vanguard Group, Real estate, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

Retrieved on: 
Thursday, December 14, 2023
The Vanguard Group, Disclosure, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited

Retrieved on: 
Thursday, December 14, 2023
UK Commercial Property Trust, Commercial property, Disclosure, The Vanguard Group, Real estate, Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8 - Molten Ventures Plc: DCC-Form 8 (DD)

Retrieved on: 
Thursday, December 14, 2023
Disclosure, Auction

(a) Full name of discloser:

Key Points: 
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) Status of person making the disclosure:
    Person acting in concert with the offeror, Molten
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.